These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2543894)

  • 1. [Action of drugs in relation to the administration route].
    Di Carlo F
    Minerva Endocrinol; 1989; 14(1):41-4. PubMed ID: 2543894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoral routes of estrogen administration.
    Cedars MI; Judd HL
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):269-98. PubMed ID: 3306522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.
    Clemente C; Russo F; Caruso MG; Giangrande M; Fanizza G; Di Leo A
    Horm Metab Res; 1992 Apr; 24(4):191-3. PubMed ID: 1318259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of estrogens used in the treatment of menopause].
    Basdevant A; Panotopoulos G
    Rev Prat; 1993 Dec; 43(20):2638-43. PubMed ID: 8146564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transdermal estrogenic therapy in menopause].
    Nencioni T; Polvani F; Penotti M; Porcaro E; Barbieri Carones M
    Minerva Endocrinol; 1989; 14(1):49-52. PubMed ID: 2543896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
    Helgason S
    Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do different delivery systems of estrogen therapy influence serum lipids differently in surgically menopausal women?
    Baksu B; Davas I; Agar E; Akyol A; Uluocak A
    J Obstet Gynaecol Res; 2007 Jun; 33(3):346-52. PubMed ID: 17578365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in lipoproteins with various sex steroids.
    Teran AZ; Greenblatt RB; Chaddha JS
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B; Baksu A; Göker N; Citak S
    Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.